Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial-Reference-Cited by-同舟云学术

Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial

Published:2017-02 Issue:2 Volume:18 Page:241-250
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Dimopoulos Meletios A,Trotman Judith,Tedeschi Alessandra,Matous Jeffrey V,Macdonald David,Tam Constantine,Tournilhac Olivier,Ma Shuo,Oriol Albert,Heffner Leonard T,Shustik Chaim,García-Sanz Ramón,Cornell Robert F,de Larrea Carlos Fernández,Castillo Jorge J,Granell Miquel,Kyrtsonis Marie-Christine,Leblond Veronique,Symeonidis Argiris,Kastritis Efstathios,Singh Priyanka,Li Jianling,Graef Thorsten,Bilotti Elizabeth,Treon Steven,Buske Christian

Publisher

Elsevier BV

Subject

Oncology

Reference26 articles.

1. Waldenström's macroglobulinemia: an indolent B-cell lymphoma with distinct molecular and clinical features;Treon;Hematol Oncol,2013

2. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus;Dimopoulos;Blood,2014

3. How to manage Waldenström's macroglobulinemia;Buske;Leukemia,2013

4. Buske C, Sadullah S, Kastritis E, et al. Treatment and outcome patterns in patients with relapsed Waldenström's macroglobulinemia: development of a large observational Pan-European data platform. The 21st European Hematology Association Annual Congress; Copenhagen, Denmark; June 9–12, 2016. Abstr E1275.

5. Rituximab intolerance in patients with Waldenström macroglobulinaemia;Castillo;Br J Haematol,2016

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network;Frontiers in Hematology;2024-06-20

2. Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy;Current Oncology Reports;2024-06-14

3. Optimizing BTK Inhibition in Waldenström Macroglobulinemia;Journal of the National Comprehensive Cancer Network;2024-05

4. Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia;Current Hematologic Malignancy Reports;2024-03-27

5. Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia;Blood Science;2024-01